CAPITALBIO
LIVE

Serial Number

79017322

Owner

Capital Bio Corporation

Attorney

Sarah L. Bruno

Filing Date

Aug 3, 2005

Add to watchlist:

No watchlists yet
View on USPTO

CAPITALBIO Trademark

Serial Number: 79017322 • Registration: 3499204

CAPITALBIO is a trademark filed by Capital Bio Corporation on August 3, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Capital Bio Corporation

18 Life Science Parkway

Entity Type: 16

CAPITALBIO CORPORATION

18 Life Science Parkway
Beijing 102206 , CN

Entity Type: 16

Trademark Details

Filing Date

August 3, 2005

Registration Date

September 9, 2008

Published for Opposition

June 24, 2008

Goods & Services

Laboratory incubators for bacteria culture; chromatography apparatus for laboratorial applications; diagnostic apparatus for determining the content of veterinary drug residues in food samples; apparatus for physical chemical testing, namely, plant metabolite analyzer and profiler apparatus; apparatus and instruments for measuring, testing and analyzing physical and chemical ingredients for laboratory use; apparatus and instruments for measuring physical properties of matter and energy; apparatus and instruments for measuring and testing chemical and biochemical compositions, structures, properties and reactions for laboratory use in scientific research; apparatus and instruments for non-medical detection and analysis of manufacturing techniques in the composition of biochips made from organic molecules; non-medical diagnostic apparatus and instruments for use in the application of medical biochip manufacturing techniques

Solvents for dissolving bacteriological cultures for laboratory use; bacterial preparations for medical and veterinary applications; chemical-pharmaceutical preparations for use in medical diagnosis and medical diagnostic testing; nutritive substances for microorganism cultures; culture medium of bacteriological microorganisms for medical and veterinary applications; biological preparations for medical applications; chemical preparations for pharmaceutical applications; diagnostic preparations for medical applications; chemical preparations for medical or veterinary applications; preparations for trace elements for human and animal use as dietary food supplements; semen for artificial fertilization; soil disinfectants; chemical preparations for medical applications

Surface active chemical agents for use in the manufacture of slides, beads and particles; anti-animalcule preparations used in food and medicine to prevent micro-organisms; chemical preparations for scientific applications; chemical reagents for research purposes; chemical reagents for use in scientific apparatus for chemical or biological analysis, namely, phosphate buffer, polyethylene glycol (PEG), dextran, and silane reagents for surface treatment; chemical preparations used for analysis in laboratories, namely solvents for use in the separation, isolation and purification of biologically active substances in bacteriological cultures, namely DMSO, ethanol, and glycerol; chemical preparations for scientific analyses in laboratories; cryogenic preparations for preservation of biological products; diagnostic preparations other than for medical or veterinary applications; reagent papers for scientific research; chemical test papers; biological preparations for scientific and laboratory research;bacteriological preparations for use in food manufacture and cosmetic manufacture other than for medical and veterinary applications; media cultures of microorganisms for use in scientific research and testing and not for medical and veterinary applications; bacteriological preparations to create acidification in laboratory research

Incubators for medical applications; medical instruments, namely, micro array biochip scanners for testing, analyzing, and evaluating biological samples for medical applications; analysis instruments for medical treatment applications, namely, automated and semi-automated chemiluminescent immunoassay analyzer, automated biochemical analyzer, automated nucleic acid extractor; diagnostic apparatus for medical applications, namely, real-time PCR machine, liquid handling machine; apparatus for diagnosing human genetic disease, infection disease, cardiac disease, tumor, diabetes, by the application of biochip techniques; medical apparatus and instruments for detection and analysis of human genetic disease or infection disease, cardiac disease, tumor, diabetes, by the application of biochip technique

Research and development of new products for others; technical research in the fields of molecular typing, protomics, system biology, genetics, genomic medicine, molecular medicine, health care, diagnostics, biosafety, forensic science, conducting high-throughput technique services in multi-field including nucleic acid, protein, cell, tissue, while employing microarray platforms; conducting technical project studies in the field of molecular typing, protomics, genetics, genomic medicine, molecular medicine, health care, diagnostics, biosafety, forensic science, conducting high-throughput technique services in the multi-field including nucleic acid, protein, cell, tissue, while employing microarray platforms; chemical analyses; chemical laboratory services, namely, synthesis, surface chemistry, reagents; chemical research; bacteriological research; biological research; rental of scientific laboratory apparatus for use in biochip research; rental of laboratory apparatus and instruments for detection and analysis of medical conditions and diseases by the application of biochip technique; providing medical diagnostic services by the application of biochip technique; quality control for others; providing quality assurance services by evaluating research controls and detecting area for improvement

Filing History

INTERNATIONAL REGISTRATION RENEWED
Jul 17, 2025 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 13, 2018 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 13, 2018 71AG
TEAS SECTION 71 RECEIVED
Sep 6, 2018 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 9, 2017 REM4
INTERNATIONAL REGISTRATION RENEWED
Aug 20, 2015 RNWL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 17, 2015 TCCA
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 17, 2014 NA71
REGISTERED-SEC.71 ACCEPTED
May 17, 2014 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 17, 2014 APRE
REGISTERED-SEC.71 FILED
May 12, 2014 71AF
TEAS SECTION 71 RECEIVED
May 12, 2014 ES71
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2013 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 29, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 6, 2009 FICS
FINAL DISPOSITION PROCESSED
Jan 6, 2009 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 9, 2008 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 9, 2008 R.PR
PUBLISHED FOR OPPOSITION
Jun 24, 2008 PUBO
NOTICE OF PUBLICATION
Jun 4, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 16, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2008 CNSA
AMENDMENT FROM APPLICANT ENTERED
Apr 18, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2008 CRFA
ASSIGNED TO LIE
Apr 18, 2008 ALIE
PAPER RECEIVED
Apr 16, 2008 MAIL
CHANGE OF OWNER RECEIVED FROM IB
Dec 14, 2007 CHLD
NON-FINAL ACTION MAILED
Nov 21, 2007 CNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2007 CNRT
UNDELIVERABLE MAIL - NO ACTION TAKEN
Jun 28, 2007 UNDN
NON-FINAL ACTION MAILED
May 24, 2007 CNRT
NON-FINAL ACTION WRITTEN
May 24, 2007 CNRT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 17, 2007 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 3, 2007 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 3, 2007 OPNR
UNDELIVERABLE MAIL - NO ACTION TAKEN
Dec 5, 2006 UNDN
NON-FINAL ACTION MAILED
Oct 26, 2006 CNRT
NON-FINAL ACTION WRITTEN
Oct 25, 2006 CNRT
AMENDMENT FROM APPLICANT ENTERED
Oct 10, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2006 CRFA
PAPER RECEIVED
Sep 11, 2006 MAIL
REFUSAL PROCESSED BY IB
Mar 30, 2006 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2006 RFCS
REFUSAL PROCESSED BY MPU
Mar 8, 2006 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2006 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2006 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2006 DOCK
NEW APPLICATION ENTERED
Dec 2, 2005 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 1, 2005 REPR